Phase II trial of mirtazapine for cancer-related cachexia and anorexia.
about
Mirtazapine inhibits tumor growth via immune response and serotonergic systemCancer Cachexia: It Takes a Team to Fix the Complex Machinery.Review of the use of mirtazapine in the treatment of depression.Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment.Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review.Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 BalanceLet them eat during dialysis: an overlooked opportunity to improve outcomes in maintenance hemodialysis patients.Diets and enteral supplements for improving outcomes in chronic kidney disease.A review of therapeutic uses of mirtazapine in psychiatric and medical conditions.Palliative care concepts in respiratory disease.A systematic review of health-related quality of life instruments in patients with cancer cachexia.Psychopharmacology in psycho-oncology.Effect of Mirtazapine on Gastric Emptying in Patients with Cancer-associated Anorexia.The oncology palliative care clinic at the Princess Margaret Cancer Centre: an early intervention model for patients with advanced cancer.Mirtazapine protects against cisplatin-induced oxidative stress and DNA damage in the rat brain.Mirtazapine toxicity in cats: retrospective study of 84 cases (2006-2011).Cancer Cachexia: Cause, Diagnosis, and Treatment.
P2860
Q28481311-32A0CB2D-34A3-41A2-95FD-4B5B388EADE7Q33756627-B0795762-4824-4A90-9226-DD31866CC103Q34190102-64D7C787-0179-43F9-8FDF-90C2F0972208Q34470745-6BD24B1E-7495-4244-99D9-16CE00ECF156Q35143365-0C07FC72-866D-41C3-A4AF-C5399C16E6D2Q36067334-55FFDC7B-9BB1-49C1-97E6-C2FE04EDECE4Q36785177-C1FB5FEC-7457-41FA-B0A9-AC96A5307426Q37421911-4DA1F7A7-FDEB-421B-BFFA-24887470CDFCQ37533880-052761BB-E693-48FC-B5B7-00B836F5B27EQ37960814-2662966A-9734-4DE6-9055-D1E163F6FBDDQ38116773-8FC42974-F487-48FF-B262-2E9BD0E07E06Q38129301-8952C8A9-B9A6-4D04-BD1D-97BE9A4894EFQ41274026-DA1F5F10-C35B-467E-A87A-DFA7EEE3786FQ44837278-BC120D39-A1AD-4CE9-97BF-5EE1155A9D47Q48230329-D4DD5AF9-FBF0-4B22-9687-3167376EDA00Q53400548-BB563CC1-239E-47FE-B272-8CB05B2CAA33Q53762212-6FF88628-FEED-4445-ABC1-EAE834E92ECB
P2860
Phase II trial of mirtazapine for cancer-related cachexia and anorexia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Phase II trial of mirtazapine for cancer-related cachexia and anorexia.
@en
Phase II trial of mirtazapine for cancer-related cachexia and anorexia.
@nl
type
label
Phase II trial of mirtazapine for cancer-related cachexia and anorexia.
@en
Phase II trial of mirtazapine for cancer-related cachexia and anorexia.
@nl
prefLabel
Phase II trial of mirtazapine for cancer-related cachexia and anorexia.
@en
Phase II trial of mirtazapine for cancer-related cachexia and anorexia.
@nl
P2093
P2860
P356
P1476
Phase II trial of mirtazapine for cancer-related cachexia and anorexia.
@en
P2093
Camilla Zimmermann
Debika Burman
Gary Rodin
Ian F Tannock
Rachel P Riechelmann
P2860
P304
P356
10.1177/1049909109345685
P577
2009-09-23T00:00:00Z